Q1 EARNINGS: Baxter's sales rise 15%, earnings beat forecast
This article was originally published in Clinica
Executive Summary
Baxter International's worldwide sales increased 15% to $3.95bn in the first quarter of 2014 based on a hearty contribution from products added to its portfolio with the $4bn acquisition of Gambro last year.